| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 461.4K | $6.69M | - | |
| CEO | 422.6K | $6.13M | - | |
| Dir | 416.7K | $6.04M | - | |
| Other | 328.4K | $4.76M | - | |
| Other | 267.2K | $3.87M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2021 | Asaf Danziger61 | Chief Executive Officer | Sell | 97,973 | $196.34 | $19,236,322.54 | -92.3% | -2.9% | -56.0% | |
| Apr 13, 2021 | Ely Benaim73 | Chief Medical Officer | Sale+OE | 5,958 | $200.00 | $1,191,600.00 | -15.2% | -2.9% | -56.0% | |
| Apr 13, 2021 | Gabriel Leung78 | Director | Sale+OE | 6,000 | $198.84 | $1,193,035.00 | -7.7% | -2.9% | -56.0% | |
| Apr 1, 2021 | William F Doyle55 | Executive Chairman | Sale+OE | 7,928 | $134.12 | $1,063,303.36 | -1.2% | +66.3% | -34.3% | |
| Mar 23, 2021 | Uri Weinberg74 | Chief Science Officer | Sale+OE | 3,892 | $140.00 | $544,880.00 | -9.7% | +58.5% | -41.4% | |
| Mar 9, 2021 | Pritesh Shah75 | Chief Commercial Officer | Sell | 6,151 | $130.97 | $805,588.52 | -5.7% | - | - | |
| Mar 8, 2021 | Frank X Leonard76 | Chief Development Officer | Sell | 765 | $130.81 | $100,066.59 | -0.8% | - | - | |
| Mar 8, 2021 | Todd Christopher Longsworth | General Counsel | Sell | 2,404 | $130.81 | $314,457.62 | -3.4% | - | - | |
| Mar 8, 2021 | Ashley Cordova76 | Chief Financial Officer | Sell | 765 | $130.81 | $100,066.59 | -2.1% | - | - | |
| Mar 8, 2021 | Wilhelmus Cm Groenhuysen65 | Chief Operating Officer | Sell | 3,004 | $130.81 | $392,941.22 | -1.9% | - | - |